Drug profile

The FDA adverse-event record for Fluorescein Stain

Name: Fluorescein Stain - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

11 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Fluorescein Stain. See the species affected, top reactions, and outcomes below.

11
adverse-event reports: 0.0%
death-coded share: Dog
most-reported species: 5
Corneal ulcer - top reaction

Compiled by PlainBreed Editorial, Pet Health Editorial Team

Verify with FDA CVM →

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

Fluorescein Stain

Administration Routes

UnknownOphthalmicOther

Species Affected

Dog 9

Cat 1

Human 1

Most Affected Breeds

Crossbred Canine/dog 2

Bulldog 1

Retriever - Golden 1

Domestic Shorthair 1

Bulldog - French 1

Shih Tzu 1

Spitz - American Eskimo Dog 1

Terrier - Yorkshire 1

Unknown 1

Pug 1

Most Reported Reactions

Corneal ulcer 5

Lethargy (see also Central nervous system depression in 'Neurological') 3

Chemosis 2

Conjunctivitis 2

Shaking 2

Blepharospasm 2

Eye irritation 2

Eye disorder NOS (for photophobia see 'neurological') 2

Uncomfortable 2

Keratoconjunctivitis sicca 2

Dry nose 2

Eye pain 2

Outcome Breakdown

Recovered/Normal

5 (45.5%)

Outcome Unknown

3 (27.3%)

Ongoing

2 (18.2%)

Recovered with Sequela

1 (9.1%)

Fluorescein Stain Adverse Event Insights

11 reports name Fluorescein Stain; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Fluorescein Stain. Administration routes: Unknown, Ophthalmic, Other.

By species: Dog (9 reports), Cat (1 reports), Human (1 reports). By breed: Crossbred Canine/dog (2), Bulldog (1), Retriever - Golden (1).

Leading clinical signs: Corneal ulcer (5), Lethargy (see also Central nervous system depression in 'Neurological') (3), Chemosis (2), Conjunctivitis (2). Outcome, 11 coded reports: Recovered/Normal leads at 45.5%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.